Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01755455 · ClinicalTrials.gov registry record · NA
Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01755455 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 22 participants.
The verdict
NCT01755455, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
This study questions whether low-dose ferrous sulfate taken by mouth daily for 6 weeks increases hemoglobin concentration in adult subjects with cystic fibrosis and hypoferremic anemia.
Interventions
- DRUG Placebo
- DRUG Ferrous sulfate 325mg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2011-06 |
| Est. Completion | 2012-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01755455
The ClinicalTrials.gov registry entry for NCT01755455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01755455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01755455 about?
NCT01755455 is a clinical study titled "Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis". This study questions whether low-dose ferrous sulfate taken by mouth daily for 6 weeks increases hemoglobin concentration in adult subjects with cystic fibrosis and hypoferremic anemia.
What is the current status of trial NCT01755455?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2011-06. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01755455?
The interventions under investigation include: Placebo (DRUG), Ferrous sulfate 325mg (DRUG).
Who is sponsoring clinical trial NCT01755455?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.